Physician profile
Michael D Howard
NPI 1245228386
$457.86
in general payments reported to CMS, 2019-2025
15 companies · $23.71 in 2025
The $23.71 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $13.97 · 2021: $78.55 · 2023: $136 · 2025: $23.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $87.77 | 2019-2023 | Watchman Access System |
| Novo Nordisk INC | $67.84 | 2019 | |
| Pylant Medical | $52.84 | 2023-2025 | |
| Pfizer INC. | $44.65 | 2019-2023 | |
| Abbvie INC. | $44.54 | 2021 | |
| Novartis Pharmaceuticals Corporation | $30.10 | 2019 | |
| Amgen INC. | $19.56 | 2021 | |
| Allergan, INC. | $16.77 | 2019 | |
| Emd Serono, INC. | $14.93 | 2023 | Tepmetko |
| Takeda Pharmaceuticals U.S.A., INC. | $14.45 | 2021 | |
| Amarin Pharma, INC. | $14.14 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.97 | 2020 | |
| Sanofi Pasteur INC. | $13.32 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.12 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.